Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
1
|
Resverlogix Corp.
|
May 09, 2022 02:44PM
|
From Sarah In IR
|
3
|
Resverlogix Corp.
|
May 08, 2022 07:32PM
|
Re: keep doing PPs at .48/shr with a .50 warrant good till 2025 donny
|
1
|
Resverlogix Corp.
|
May 08, 2022 01:27PM
|
Re: BTD
|
1
|
Resverlogix Corp.
|
Apr 25, 2022 09:26PM
|
Re: Exempt Distribution - 2022-04-14
|
2
|
Resverlogix Corp.
|
Apr 18, 2022 06:37PM
|
Re: Seems to be some interest
|
2
|
Resverlogix Corp.
|
Apr 12, 2022 03:24PM
|
Re: COVID 19 / varients
|
2
|
Resverlogix Corp.
|
Apr 10, 2022 05:38PM
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
4
|
Resverlogix Corp.
|
Apr 06, 2022 01:22PM
|
IS THIS SITE DOWN
|
1
|
Resverlogix Corp.
|
Apr 04, 2022 03:44PM
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
8
|
Resverlogix Corp.
|
Mar 20, 2022 02:52PM
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
2
|
Resverlogix Corp.
|
Mar 20, 2022 02:37PM
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
4
|
Resverlogix Corp.
|
Mar 20, 2022 02:33PM
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
1
|
Resverlogix Corp.
|
Mar 20, 2022 02:32PM
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
5
|
Resverlogix Corp.
|
Mar 20, 2022 02:27PM
|
Re: So I was able to finally set up a one on one meeting with...
|
5
|
Resverlogix Corp.
|
Mar 14, 2022 11:19PM
|
Re: Deja Vu All Over Again
|
2
|
Resverlogix Corp.
|
Mar 13, 2022 08:12PM
|
Re: Deja Vu All Over Again
|
5
|
Resverlogix Corp.
|
Mar 12, 2022 08:56PM
|
Re: Deja Vu All Over Again
|
1
|
Resverlogix Corp.
|
Mar 12, 2022 08:52PM
|
Re: Deja Vu All Over Again
|
3
|
Resverlogix Corp.
|
Mar 12, 2022 08:50PM
|
Re: Deja Vu All Over Again
|
1
|
Resverlogix Corp.
|
Mar 10, 2022 03:30PM
|